 - No significant cardiovascular diseases i.e. uncontrolled hypertension, unstable angina, history of infarction within the past 12 months prior to start of study treatment, congestive heart failure NYHA New York Heart Association Class II, serious cardiac arrhythmia, pericardial effusion 